Literature DB >> 16471961

Solution and structural investigations of ligand preorganization in trivalent lanthanide complexes of bicyclic malonamides.

Bevin W Parks1, Robert D Gilbertson, James E Hutchison, Elisabeth Rather Healey, Timothy J R Weakley, Brian M Rapko, Benjamin P Hay, Sergei I Sinkov, Grant A Broker, Robin D Rogers.   

Abstract

This report describes an investigation into the coordination chemistry of trivalent lanthanides in solution and the solid state with acyclic and preorganized bicyclic malonamide ligands. Two experimental investigations were performed: solution binding affinities were determined through single-phase spectrophotometric titrations and the extent of conformational change upon binding was investigated with single-crystal X-ray crystallography. Both experimental methods compare the bicyclic malonamide (BMA), which is designed to be preorganized for binding trivalent lanthanides, to an analogous acyclic malonamide. Results from the spectrophotometric titrations indicate that BMA exhibits a 10-100x increase in binding affinity to Ln(III) over acyclic malonamide. In addition, BMA forms compounds with high ligand-metal ratios, even when competing with water and nitrate ligands for binding sites. The crystal structures exhibit no significant differences in the nature of the binding between Ln(III) and the BMA or acyclic malonamide. These results support the conclusion that rational ligand design can lead to compounds that enhance the binding affinities within a ligand class.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16471961     DOI: 10.1021/ic050437d

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  1 in total

1.  Elucidating the 3D structures of Al(iii)-Aβ complexes: a template free strategy based on the pre-organization hypothesis.

Authors:  Jon I Mujika; Jaime Rodríguez-Guerra Pedregal; Xabier Lopez; Jesus M Ugalde; Luis Rodríguez-Santiago; Mariona Sodupe; Jean-Didier Maréchal
Journal:  Chem Sci       Date:  2017-05-09       Impact factor: 9.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.